SVB Leerink’s success in M&A is rooted in our long-term relationships. We recognize the true core asset of our firm is our clients’ trust. SVB Leerink has closed approximately 70 M&A transactions since 2013 across sectors and structures.Contact Us
SVB Leerink’s M&A advisory practice leverages the same proprietary insights and industry relationships that drive our leading capital markets franchise. SVB Leerink’s senior advisory team guides our clients through acquisitions, sales, divestitures, and other corporate restructurings.
M&A Advisory Team
Senior Managing Director, Mergers & Acquisitions
Dan Lepanto is a Senior Managing Director at SVB Leerink and is an integral part of the Mergers & Acquisitions team.
Prior to joining the firm in 2008, Mr. Lepanto spent 10 years in various roles, most recently as Managing Director, at Cowen and Company where he executed mergers and acquisitions for clients in a number of sub-sectors of the Healthcare industry. Prior to joining Cowen and Company, Mr. Lepanto was a member of the Mergers & Acquisitions group at Wasserstein Perella. Mr. Lepanto has worked on many transactions including the announced sale of Huntsman to Hexion / Apollo Management, the sale of NPS to Shire, the sale of Cynosure to Hologic, the sale of TKT to Shire, the sale of GelTex to Genzyme, the merger of Total Renal Care with Renal Treatment Centers and the acquisition of Vivra by Gambro.
Mr. Lepanto earned his B.S. in Finance with High Honors from Pennsylvania State University.